"A company, will rarely go bust in the face of heavy insider buying." Peter Lynch
Good morning
Trade war fears are front and center with equities selling off around the globe. Oil is also pulling back in premarket heading into the OPEC meeting and rumors that those talks could be difficult as well. With equities tanking you would think gold would be ripping however gold is only slightly up at the moment with the dollar showing some strength. Small caps and micro caps have been strong in this trade war environment and that theme could continue. The big industrial and multinational names are likely going to feel continued pressure.
AMPH Amphastar Reports Approval for Isoproterenol Hydrochloride Injection, USP; Anticipates Launching Product In Q3 2018 not reacting in premarket looking for a 17 test and roll day trade small float
ARWR Arrowhead Pharmaceuticals On Monday Closed Up 23.8% After Co. Completed Enrollment in Phase 1 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease potential red to green move day trade opp nice breakout on the daily
OMP Credit Suisse Initiates Coverage On Oasis Midstream Partners with Neutral Rating, Announces $19.00 Price Target small floater look for 17 to hold as support Oasis Midstream Partners Raises FY18 Capex Guidance: Bighorn Net Capex Raised From $40M-$50M To $60M-$65M, Bobcat From $14M-$16M To $16.5M-$17M, Beartooth From $18M-$24M To $24M-$26M Oil names will likely be weak could be a swing type higher risk if 17 does not hold possibly 16 would be good price support
TapImmune, Inc. (NASDAQ:TPIV) surged 17.43 percent to close at $12.33. potential follow through extended on the daily very tiny floater do not chase
VIVE Viveve Medical Shares Up 18.1% After Co. Reported Positive Six-Month Data From Stress Urinary Incontinence Feasibility Study may consolidate belwo the 200 day small floater overbought could be a day trade if 4 can hold as support
VSTM Veristem Shares Closed Up 30.9% After Co.'s Duvelisib Showed Robust Clinical Activity In CLL potential red to green follow through day
NURO spiking up 6.8% to a high of 1.78 on high volume
NeuroMetrix Reports Received $3.8M Milestone Payment Related To Collaboration With GSK Consumer Healthcare tends to be a pop and flopper do not chase bear flag on the daily very thin float
Gevo, Inc. (NASDAQ:GEVO) shares rose 37.8 percent to $17.50 in pre-market trading. Gevo shares surged around 262 percent on Monday after the EPA announced it has approved up to a 16 percent blend of isobutanol for use in automobiles. Could be another crazy day play it size appropriate do not chase
RKDA H.C. Wainwright Initiates Coverage On Arcadia Biosciences with Buy Rating, Announces $20 Price Target
Today's Economic Calendar
CGC Neptune Technologies & Bioressources Report Multi-Year Deal With Canopy Growth For Supplmenting Of Canopy's Extraction, Refinement, Extract Product Formulation Capacity potential swing trade opp looking for 2.70 entry
7:00 Fed's Bullard Speech
8:30 Housing Starts
8:55 Redbook Chain Store Sales
